A Pathophysiological Model of Parkinson’s Disease Based on Microvascular Flow Disturbance and Leukocyte-Mediated Oxidative Injury in Critical Pigmented Neuronal Niches
The authors hypothesize that idiopathic Parkinson's disease may result from an alteration in microvascular flow at a "critical point" in the nervous system that is characterized by pigmented cells that express neuromelanin and/or lipofuscin. "Critical points" include the olfactory epithelium/bulb, the autonomic nervous system, the enteric nervous system, the prefrontal-cortico-pontine network, and the amygdala. Hypoxia-ischemia following blood flow disturbance would recruit and activate leukocytes and induce the infiltration of peripheral immune cells into neural tissue. The excess of toxic factors produced by hyperactive immune cells, such as myeloperoxidase and its derivatives, would cause the oxidation of lipids, proteins, and biogenic monoamines such as dopamine, which in turn would facilitate the accumulation and precipitation of neuromelanin, lipofuscin, and alpha-synuclein. In addition, neuromelanin and lipofuscin precipitates may accentuate the misfolding and aggregation of alpha-synuclein. This "amplification" mechanism could help explain the crucial role of pigmented neurons in the onset of Parkinson's disease pathology, triggering abnormal neurotoxic alpha-synuclein spread throughout the nervous system from the "critical point" of origin, and enabling a self-perpetuating degenerative process. The proposed hypothesis may have implications for the identification of new therapeutic targets, early prevention strategies, and the development of vascular and/or immune biomarkers.
Authors
- Emilio Fernández-Espejo
- Fernando Rodríguez de Fonseca
Institutions
- Instituto de Ciencia de Materiales de Sevilla (ES)
- Instituto de Investigación Biomédica de Málaga (ES)
Publication Details
- Journal
- Antioxidants
- Published
- 2026-02-03
- DOI
- https://doi.org/10.3390/antiox15020201
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Commission
- Sociedad Andaluza de Neurología
- Junta de Andalucía
- HORIZON EUROPE Framework Programme
- Instituto de Salud Carlos III